Literature DB >> 2692037

What is synergy?

M C Berenbaum1.   

Abstract

Mesh：

Year:  1989        PMID： 2692037

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  337 in total

1.  In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.

Authors:  D Colledge; G Civitico; S Locarnini; T Shaw
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Drug-drug pharmacodynamic interaction detection by a nonparametric population approach. Influence of design and of interindividual variability.

Authors:  Y Merlé; A Mallet; E Schmautz
Journal:  J Pharmacokinet Biopharm       Date:  1999-10

3.  Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.

Authors:  Yanmei Hu; Jiantao Zhang; Rami Ghassan Musharrafieh; Chunlong Ma; Raymond Hau; Jun Wang
Journal:  Antiviral Res       Date:  2017-08-02       Impact factor: 5.970

4.  Synergy and its clinical reievance in topical acne therapy.

Authors:  Leon H Kircik
Journal:  J Clin Aesthet Dermatol       Date:  2011-11

Review 5.  Revisiting the isobole and related quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2012-04-17       Impact factor: 4.030

6.  The optimal deployment of synergistic antibiotics: a control-theoretic approach.

Authors:  Rafael Peña-Miller; David Lähnemann; Hinrich Schulenburg; Martin Ackermann; Robert Beardmore
Journal:  J R Soc Interface       Date:  2012-05-23       Impact factor: 4.118

7.  Comparing nonsynergistic gamma models with interaction models to predict growth of emetic Bacillus cereus when using combinations of pH and individual undissociated acids as growth-limiting factors.

Authors:  Elisabeth G Biesta-Peters; Martine W Reij; Leon G M Gorris; Marcel H Zwietering
Journal:  Appl Environ Microbiol       Date:  2010-07-16       Impact factor: 4.792

Review 8.  A few specialized issues that should be focused on anti-HIV drug evaluation in vitro.

Authors:  Dao-min Zhuang; Jing-yun Li
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

9.  A multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteins.

Authors:  Gajendra W Suryawanshi; Alexander Hoffmann
Journal:  J Theor Biol       Date:  2015-09-16       Impact factor: 2.691

10.  Biguanide-atovaquone synergy against Plasmodium falciparum in vitro.

Authors:  K Jones; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.